Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CHPA Year In Review: Legislative Accomplishments, OTC Product Awareness And Goals For 2006

This article was originally published in The Tan Sheet

Executive Summary

The Consumer Healthcare Products Association speaks to "The Tan Sheet" about the group's accomplishments in 2005 and plans for 2006. The 125 year-old trade association represents the interests of the consumer healthcare and over-the-counter drugs industries. Find below excerpts from an interview with CHPA President Linda Suydam and Vice President - Government Relations Kevin Kraushaar

You may also be interested in...



Anti-Meth Draft Places PSE Behind Counter, Lacks Schedule V Language

Current draft report language in the Patriot Act places all pseudoephedrine products behind the counter but does not contain a Schedule V provision, according to the Consumer Healthcare Products Association

Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”

Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement

Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”

Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099000

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel